AzTrials
AzTrials

Gestational DiabetesNCT05148897

Awareness of Gestational Diabetes Among Sohag Governorate Women

An observational study of Gestational Diabetes, run by Sohag University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The type of the study is a cross sectional descriptive using questionnaire method in Sohag governorate among 500 Women, over 6 months by random selection and they will be asked to answer the questions of prepared and copied questionnaire sheet. Inclusion criteria: all women can participate in this questionnaire. Read more about this study

Who is it for?
Ages 13 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Gestational Diabetes
What is being tested?
Questionnaire
How many people
500 participants
Where
1 siteEgypt
Study dates
1 Oct 2021to 1 Apr 2022
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: cross sectional descriptive using questionnaire method in Sohag governorate among 500Women, over 6 months by random selection

Who may be able to join

  • All Females

Who cannot join

  • There is no Exclusion Criteria:

Trial locations and contacts

1 site in 1 country.

Eslam E Mohamed Fawzy, Doctor contact

0109 386 0560

eslam.emad8275@gmail.com

Hamdy s Mohamed, Ass.Prof contact

01111101934

hamdy119@yahoo.com

Egypt1 site, 1 recruiting
  • Sohag University

    Sohag

    Eslam E awesh, doctor, 0109 386 0560, eslam.emad8275@gmail.com

    Eslam E Mohamed Fawzy, doctor

    Recruiting

Other trials in Egypt

About this study

Official title: Study of Awareness of Gestational Diabetes Problem Among Sohag Governorate Women

The type of the study is a cross sectional descriptive using questionnaire method in Sohag governorate among 500 Women, over 6 months by random selection and they will be asked to answer the questions of prepared and copied questionnaire sheet.

Inclusion criteria: all women can participate in this questionnaire.

Read the detailed description

the study is a cross sectional descriptive using questionnaire method in Sohag governorate among 500 women, over 6 months by random selection and they will be asked to answer the questions of prepared and copied questionnaire sheet. Data was collected by using a self-administered questionnaire. Based on extensive literature review no questionnaire was found that specifically related to knowledge evaluation. The basic theme of the questionnaire was taken from Diabetes Knowledge Questionnaire (DKN), a well validated tool for knowledge assessment among type 1 and type 2 diabetes mellitus patients. Some modifications were made and new questions particularly related to Gestational Diabetes Mellitus (GDM) were included. Final version of questionnaire consists of 15questions divided into five main categories which are basic knowledge about GDM(3 questions), risk factors (3 questions), food and diet values (3 questions), management(3 questions)and complications/outcomes (3 questions). All questions were in multiple choice format with one option was "I don't know "to avoid unnecessary guesses by the participants. Score 1 was given to every right answer and 0 to every wrong answer. A higher score indicates better knowledge about GDM. Thus the maximum score is 15 and minimum is 0 and other questions without score to know the patient himself and to assess the relationship between the residency, work, education level and knowledge of patient and family history.

A standardized questionnaire will focus on:

  1. Personal Data
  2. Basic Knowledge about GDM
  3. Knowledge about risk factors of GDM
  4. Knowledge about diet/food values
  5. Knowledge about management of GDM
  6. Knowledge about GDM complications/outcomes
Being tested
Questionnaire
Medical subject headings
Diabetes, Gestational

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    a self-administered questionnaire. Based on extensive literature review no questionnaire was found that specifically related to knowledge evaluation. The basic theme of the questionnaire was taken from Diabetes Knowledge Questionnaire (DKN), a well validated tool for knowledge assessment among type 1 and type 2 diabetes mellitus patients. Some modifications were made and new questions particularly related to GDM were included.

Study groups in NCT05148897
Study groupRoleWhat they receive
All Women can participateamong 500 women, over 6 months by random selection and they will be asked to answer the questions of prepared and copied questionnaire sheet.
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate general knowledge of women about different aspects of Gestational Diabetes: Questionnaire

    All the statistical analysis will be done by using Statistical Package for Social Sciences (SPSS Inc., Chicago, IL) version20. Number and percentage will be used for grouped variables whereas mean and standard deviation will be used for continuous variables. Responses to all questions of the questionnaire will be recorded in numbers and percentages. Association of demographic characteristics with knowledge score

    Measured: Change the literacy of knowledge of women about different aspects of Gestational Diabetes at 6 months after the questionnaire

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2021
  2. Study start1 Oct 2021
  3. Primary completion1 Mar 2022 (estimated)
  4. Study completion1 Apr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
500 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT05148897
Sponsor's protocol ID
Soh-Med-21-11-05
Status last verified
Nov 2021
First submitted
10 Nov 2021
Last updated
8 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: knowledge of women about different aspects of Gestational Diabetes Mellitus including general knowledge about the disease, risk factors, diet in diabetic patients and complications among the women in Sohag governorate ad the questionnaire itself

Publications

  • Atlas, D.J.I.D.A., 9th: International Diabetes Federation, International diabetes federation. 2020

  • Eltoony, L.F., et al., Prevalence and Risk Factors for Gestational Diabetes in Aswan, Egypt According to International Association of the Diabetes and Pregnancy Study Groups (IADPSG). 2021. 82(4): p. 701-707.

  • O'Sullivan EP, Avalos G, O'Reilly M, Dennedy MC, Gaffney G, Dunne F; Atlantic DIP collaborators. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia. 2011 Jul;54(7):1670-5. doi: 10.1007/s00125-011-2150-4. Epub 2011 Apr 15.

    PubMed 21494772
  • Farrar D. Hyperglycemia in pregnancy: prevalence, impact, and management challenges. Int J Womens Health. 2016 Sep 20;8:519-527. doi: 10.2147/IJWH.S102117. eCollection 2016.

    PubMed 27703397
  • Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998 Aug;21 Suppl 2:B161-7. No abstract available.

    PubMed 9704245
  • Khan R, Bisnath J, Blackmann J, Bissessar R, Bidhesi S, Boodoo N, Bobb T, Benjamin J, Mohammed A, Mahabir A. Prevalence rates of impaired glucose tolerance and gestational diabetes mellitus amongst expectant mothers and undiagnosed diabetes mellitus in walk-in patients at health centres in North Central Trinidad. J Family Med Prim Care. 2020 Jun 30;9(6):3112-3118. doi: 10.4103/jfmpc.jfmpc_124_20. eCollection 2020 Jun.

    PubMed 32984182
  • Muche AA, Olayemi OO, Gete YK. Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis. Arch Public Health. 2019 Aug 6;77:36. doi: 10.1186/s13690-019-0362-0. eCollection 2019.

    PubMed 31402976
  • Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O. Epidemiology of and Risk Factors for Type 2 Diabetes in Egypt. Ann Glob Health. 2015 Nov-Dec;81(6):814-20. doi: 10.1016/j.aogh.2015.12.011.

    PubMed 27108148
  • Cavanaugh KL. Health literacy in diabetes care: explanation, evidence and equipment. Diabetes Manag (Lond). 2011 Mar;1(2):191-199. doi: 10.2217/dmt.11.5.

    PubMed 21860659
  • Lee KW, Ching SM, Ramachandran V, Yee A, Hoo FK, Chia YC, Wan Sulaiman WA, Suppiah S, Mohamed MH, Veettil SK. Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018 Dec 14;18(1):494. doi: 10.1186/s12884-018-2131-4.

    PubMed 30547769
  • Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007 Aug;30(8):2070-6. doi: 10.2337/dc06-2559a. Epub 2007 Apr 6.

    PubMed 17416786
  • Cheung NW. The management of gestational diabetes. Vasc Health Risk Manag. 2009;5(1):153-64. doi: 10.2147/vhrm.s3405. Epub 2009 Apr 8.

    PubMed 19436673
  • Hussain Z, Yusoff ZM, Sulaiman SA. Evaluation of knowledge regarding gestational diabetes mellitus and its association with glycaemic level: A Malaysian study. Prim Care Diabetes. 2015 Jun;9(3):184-90. doi: 10.1016/j.pcd.2014.07.007. Epub 2014 Aug 15.

    PubMed 25132140

Questions about this trial

What is this clinical trial studying?

An observational study of Gestational Diabetes, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eslam E Mohamed Fawzy, Doctor (0109 386 0560, eslam.emad8275@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate general knowledge of women about different aspects of Gestational Diabetes: Questionnaire (time frame: Change the literacy of knowledge of women about different aspects of Gestational Diabetes at 6 months after the questionnaire). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05148897, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in